Agoracom Blog

Fobi AI Unveils “Fobi AI 3.0” — A Unified Artificial Intelligence Platform Built for Real-World Enterprise Deployment

Posted by Brittany McNabb at 3:17 PM on Thursday, November 13th, 2025

Fobi AI Inc. (TSXV: FOBI | OTCQB: FOBIF), a data and artificial-intelligence technology company specializing in real-time customer engagement and mobile-wallet solutions, has announced the formal rollout of Fobi AI 3.0, a comprehensive strategic and operational framework designed to unify the company’s consulting, licensing, and subscription businesses under a single, AI-native model. The initiative marks a significant milestone in Fobi’s transformation into a full-service platform that integrates advisory expertise with the deployment of its proprietary AI and data-intelligence technologies.

From Real-Time Data to AI-Native Solutions

Founded in 2017, Fobi built its early reputation on providing real-time analytics and mobile-wallet activation tools that allow enterprises to create and manage digital passes, offers, and loyalty programs while capturing first-party customer data. Over time, these capabilities expanded to include broader data-intelligence and Web3-ready features, enabling the company to bridge traditional marketing systems with next-generation digital identity and automation frameworks.

The launch of Fobi AI 3.0 formalizes that progression. The company’s new structure aligns strategic advisory, technical architecture, and hands-on execution into one commercial framework—reflecting a broader industry trend where enterprises are seeking fewer handoffs between strategy consultants, system integrators, and software vendors. The approach is intended to help organizations shorten the distance between planning and measurable results.

Operational Discipline and Financial Progress

Recent filings highlight the company’s operational reset and financial resilience. For the fiscal year ended 2024, Fobi AI reported approximately $2.92 million in revenue, representing an increase of about 40% year-over-year. Alongside this growth, the company has introduced AI-enabled efficiency measures that reduced its operating burn rate by roughly 82%, setting a projected annualized run rate of approximately $1.3 million by 2026.

These actions underscore Fobi’s shift toward scalability and cost discipline, achieved while maintaining focus on client delivery and innovation. Chief Executive Officer Rob Anson stated that the company’s goal remains to “align our strategic advisory, technology, and execution capabilities under a single commercial framework” and to pursue cash-flow-positive operations by 2026.

The company has also completed the filing of its 2024 annual and 2025 interim financial statements, clearing a key regulatory hurdle and paving the way for the lifting of a previous cease-trade order. This reinstatement process restores full transparency to the market and reinforces Fobi’s commitment to regulatory compliance and corporate governance.

Fobi AI 3.0: Strategy, Architecture, and Execution

Under its new framework, Fobi AI is structured around three core pillars:

  • Strategy: Advisory services for executives focused on AI, data intelligence, mobile-wallet engagement, and Web3 readiness.

  • Technical Architecture: Design and implementation of secure, scalable systems that connect enterprise data, supply chains, and customer-intelligence tools.

  • Execution: Full deployment and optimization of programs across sectors such as retail, sports, healthcare, and events.

This model enables clients to bridge planning and deployment seamlessly—turning strategy into measurable business outcomes. The company continues to monetize through professional services, software licensing, and recurring subscriptions, supported by millions of digital-wallet interactions across its global customer base.

Positioning Within a Shifting Industry

As artificial intelligence and automation reshape enterprise operations, the consulting sector itself is evolving. Global firms are retooling to integrate AI into their offerings, yet many clients now demand partners who can not only advise but also implement. Fobi’s combination of advisory insight, proprietary AI technology, and deployment expertise positions it squarely within this emerging “execution-first” model of digital transformation.

The company’s participation in programs such as Comcast SportsTech 2024 and its active role in event, transportation, and digital-identity projects across North America illustrate how its technology stack is being applied to real-world, data-driven use cases.

Looking Ahead

Fobi AI’s evolution reflects a deliberate shift toward long-term sustainability and practical execution. With financial discipline, a streamlined cost base, and a renewed emphasis on outcome-driven AI deployment, the company is positioned to strengthen its foothold across multiple industries.

As enterprises accelerate their transition to intelligent, data-connected systems, Fobi AI 3.0 represents the company’s answer to the market’s most pressing demand—delivering not just roadmaps, but measurable results powered by real-time AI intelligence.

YOUR NEXT STEPS 

Visit $FOBI HUB On AGORACOM: https://agoracom.com/ir/FobiAI

Visit $FOBI 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/FobiAI/profile

Visit $FOBI Official Verified Discussion Forum On AGORACOM:

https://agoracom.com/ir/FobiAI/forums/discussion

Watch $FOBI Videos On AGORACOM YouTube Channel:

https://www.youtube.com/playlist?list=PLfL457LW0vdKRzZ61NXeYFyshLOXxNJO2

 

DISCLAIMER AND DISCLOSURE

 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

 

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

HPQ Silicon Global Disruption Of Fumed Silica Is Analogous To What Desktop Computers Did To Super Computers

Posted by Alavaro Coronel at 8:01 AM on Thursday, November 13th, 2025

When a company proves it can do what’s never been done before – producing commercial-grade fumed silica directly from quartz in a single step – it marks a seismic shift in a century-old industry. HPQ Silicon (TSX-V: HPQ / OTCQB: HPQFF) has just crossed that line, confirming independent pilot-scale validation of its breakthrough plasma process.

WHAT YOU NEED TO KNOW

  • Binary ON: HPQ replicated McGill-verified lab results at pilot scale — confirming commercial-grade purity and surface area.
  • Industry Validation: An LOI remains active with the largest fumed silica manufacturer in the world to evaluate pilot samples.
  • Commercial Stage Begins: Independent results open the door to direct engagement with multiple industrial buyers under NDA.
  • Canadian Advantage: Positioned to capture up to 50% of Canada’s $200M market, which currently imports 100% of its supply.
  • High-Margin Economics: Targeting ~70% gross profit margins on a market-priced product ($5K–$6K/ton).

STRATEGIC IMPLICATIONS

For decades, the global fumed silica industry — valued in the billions — has relied on a fossil-fuel-intensive process that’s toxic and expensive. HPQ’s one-step, plasma-based system eliminates hydrogen chloride, slashes CO₂ by 84%, and reduces energy use by 87%.

With federal and Québec government support funding two-thirds of its pilot costs, HPQ is now transitioning from R&D to commercialization — a rare pivot point where innovation meets execution.

CEO BERNARD TOURILLON:

“This is a massive milestone. We’ve replicated our lab results at pilot scale — a world first. That means we can now move from saying ‘we will’ to ‘we have,’ and start direct commercial discussions.”

INVESTOR TAKEAWAY

HPQ Silicon has achieved what legacy players could not: proven scalability, independent validation, and a clean, cost-efficient pathway to domestic production. With major industry interest, government alignment, and multiple verticals advancing in parallel, HPQ isn’t just innovating — it’s redefining how fumed silica will be made and monetized in the clean-tech era.

 

Quantum BioPharma Cuts Liabilities in Half, Boosts Equity 275%, and Strengthens Path to Phase 2 MS Trial

Posted by Brittany McNabb at 12:09 PM on Tuesday, November 11th, 2025

Quantum BioPharma Ltd. (NASDAQ/CSE: QNTM; FRA: 0K91) today reported a strong third quarter, marking continued progress across both financial and scientific fronts. The biopharmaceutical company, focused on developing innovative treatments for neurodegenerative, metabolic, and alcohol-related conditions, demonstrated clear operational discipline while advancing its clinical and consumer health initiatives.

Financial Turnaround Anchored by Balance-Sheet Strength

Quantum BioPharma delivered significant quarter-over-quarter improvement, underscoring the company’s strengthened financial foundation. Shareholder equity increased 275%, while the debt-to-equity ratio improved by 86%, driven largely by the full elimination of liabilities related to previously issued convertible debentures.

Total liabilities declined from US $13.2 million to US $6.6 million, and general and administrative expenses were reduced by 8%. Liquidity improved substantially, with the current ratio rising to 1.41x from 0.78x in the prior quarter. Collectively, these results reaffirm the company’s “no going concern” position and extend its cash runway beyond March 2027.

Quantum also realized US $572,000 in gains from its digital-asset portfolio, primarily Bitcoin, as part of a diversified treasury strategy. As of September 30, 2025, the company held US $5.2 million in digital assets, up from US $0.8 million at year-end 2024, further enhancing its financial flexibility.

Lucid-MS: Advancing a New Approach to Multiple Sclerosis

At the core of Quantum’s R&D pipeline is Lucid-21-302 (Lucid-MS), a patented, first-in-class oral drug candidate designed to target the underlying biology of demyelination — the process that drives nerve-fiber damage in Multiple Sclerosis (MS).

The company recently completed 3- and 6-month oral toxicity studies that showed no toxicity or adverse side effects, a key milestone supporting advancement toward a Phase 2 human efficacy trial. Lucid-MS’s oral formulation offers a convenient alternative to existing MS therapies that require injections or infusions.

Quantum has also partnered with Massachusetts General Hospital (MGH) researchers in a joint PET imaging study to validate a new approach for monitoring myelin integrity in MS patients. In parallel, the company has engaged a global pharmaceutical development organization to prepare an Investigational New Drug (IND) submission to the U.S. FDA.

“Lucid-MS represents a new direction in MS treatment — one focused on protecting myelin and addressing the biological drivers of neurodegeneration,” said Zeeshan Saeed, President and Chief Executive Officer.

Expanding Consumer Health and Diversified Assets

Beyond its pharmaceutical programs, Quantum continues to expand its portfolio of commercially active consumer health assets.

Its licensed product unbuzzd™, designed to accelerate alcohol metabolism and ease hangover symptoms, is marketed in the United States by Unbuzzd Wellness Inc. The licensee launched powder stick packs in late 2024 and has since initiated a Reg D  financing of up to US $5 million in preparation for a potential initial public offering — without any equity dilution to Quantum.

In Canada, Health Canada has granted a Product License for Qlarity™, a natural-health formulation that supports energy, metabolism, and cognitive performance. Qlarity™ complements Quantum’s broader focus on neurological health and wellness.

Sustained Progress and Long-Term Vision

The third quarter also saw continued progress in Quantum’s efforts to address alleged market manipulation of its stock. Management confirmed that all hedge-fund-held warrants have now expired, and that a special dividend of Contingent Value Rights (CVRs) was distributed to Class B shareholders in October 2025.

Looking ahead, Quantum BioPharma plans to maintain disciplined financial management while advancing its clinical and consumer-health milestones. The company’s balance-sheet strength, diversified portfolio, and advancing MS program collectively establish a foundation for sustained growth in 2026 and beyond.

With a Phase 2 trial for Lucid-MS approaching and a global consumer-health pipeline expanding, Quantum BioPharma remains positioned at the intersection of biotechnology innovation, financial resilience, and long-term therapeutic impact.

Visit $QNTM HUB On AGORACOM :https://agoracom.com/ir/Quantumbiopharma

Visit $QNTM 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/Quantumbiopharma/profile

Visit $QNTM Official Verified Discussion Forum On AGORACOM:

https://agoracom.com/ir/Quantumbiopharma/forums/discussion

 

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

 

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post. You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews/video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From 363K oz Gold to 413M lbs Nickel — Renforth Resources Powers Ahead with Dual-Track Growth Strategy

Posted by Brittany McNabb at 11:56 AM on Tuesday, November 11th, 2025

From 363K oz Gold to 413M lbs Nickel — Renforth Resources Powers Ahead with Dual-Track Growth Strategy

Renforth Resources Inc. (CSE: RFR; OTCQB: RFHRF; FSE: 9RR) continues to advance its dual focus on gold and critical minerals in Quebec’s Abitibi mining district — one of the world’s most prolific and infrastructure-rich jurisdictions. With 100% ownership of both the Parbec Gold Deposit and the Victoria Nickel-Polymetallic System, Renforth is strategically positioned at the intersection of two enduring global trends: gold’s role as a store of value and the accelerating demand for energy-transition metals such as nickel, copper, and cobalt.

Parbec Gold Deposit: Surface Work Strengthens Geological Model

Renforth recently completed a successful stripping program at the Parbec Gold Deposit, located adjacent to Agnico Eagle’s Canadian Malartic Mine. Covering approximately 2,200 square metres within the open-pit design area, the campaign marked the company’s first large-scale surface exposure program at Parbec.

Field crews identified several previously unrecognized faults and structural features intersecting the Cadillac Break — a prolific, gold-bearing corridor responsible for millions of ounces of historical production across the Abitibi. Visual observations and sampling confirmed lithologies previously observed only in drill core. These discoveries reinforce Renforth’s interpretation of Parbec as a structurally complex, open-ended system with meaningful near-surface potential.

While cold weather limited full channel sampling, grab samples were collected and dispatched for assay. Additional trenching, mapping, and sampling are planned for spring. This fieldwork supports Parbec’s updated 2025 mineral resource estimate of approximately 363,000 ounces of gold, representing a 29% increase from prior estimates, with 87% of ounces contained within an optimized open-pit shell.

Victoria Nickel-Polymetallic System: NI 43-101 Technical Report Filed

Renforth also filed its NI 43-101 Technical Report for the Malartic Metals Package, including the maiden Inferred Mineral Resource Estimate for the Victoria Nickel Sulphide Polymetallic Deposit. The resource outlines 125 million tonnes grading 0.15% nickel equivalent (NiEq) — approximately 413 million pounds of contained NiEq within a 2.5-kilometre section of a 20-kilometre-long mineralized trend.

The Technical Report confirms that Victoria remains open along strike and at depth, with drilling extending to 320 metres below surface. The open-pit model features a strip ratio of less than 1:1, indicating potential for efficient extraction. Hosted within interlayered ultramafic and black-shale units, the deposit also contains cobalt, copper, zinc, and precious-metal credits, providing exposure to multiple critical-mineral markets.

The report further highlights additional regional targets within the Malartic Metals Package — including the Beaupré copper discovery (stripped and sampled over 180 metres of strike), the Lac Surimau gold zone, and lithium anomalies near Victoria. Together, these prospects underscore the district-scale, multi-metal potential of the property, supported by ready access to roads, hydro power, and nearby processing infrastructure.

Strengthened Technical Foundation and Financing Momentum

Renforth’s field progress has been supported by the first tranche of its ongoing financing to advance exploration and technical programs across both Parbec and Victoria. The company’s disciplined strategy — combining targeted fieldwork with continued resource definition — is solidifying its technical foundation and operational readiness.

At Parbec, the emphasis on surface exposure and geologic refinement is designed to convert modeled mineralization into demonstrable, near-surface ounces. At Victoria, the completion of the NI 43-101 report establishes a baseline for future economic and development studies — a critical step in defining the project’s long-term potential.

Outlook: Balanced Growth for a Changing Market

Renforth’s dual-track strategy reflects balance and foresight — advancing a proven gold asset in a world-class mining district while building exposure to the metals essential for the energy transition. Both projects benefit from road access, grid power, and proximity to established infrastructure, enabling efficient, low-impact exploration.

As work resumes in 2026, Renforth remains focused on two complementary objectives: unlocking near-surface gold value at Parbec and expanding its nickel-polymetallic footprint at Victoria. This balanced approach continues to strengthen the company’s position as a diversified Quebec-based explorer poised to benefit from both stability in precious metals and growth in the critical-minerals economy.

YOUR NEXT STEPS

Visit $RFR HUB On AGORACOM:https://agoracom.com/ir/RenforthResources

Visit $RFR 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/RenforthResources/profile

Visit $RFR Official Verified Discussion Forum On AGORACOM:https://agoracom.com/ir/RenforthResources/forums/discussion

 

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

 

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

 

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

 

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

 

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visithttps://agoracom.com/terms-and-conditions

 

UAE Commits $10B to RWA Tokenization Right As AGORACOM Accelerates Tokenization Of Small Cap Companies Assets

Posted by AGORACOM-JC at 1:12 PM on Monday, November 10th, 2025

GFG logo served with static path of public directory

The UAE just made it official: over $10 billion in real-world assets are being tokenized through regulated blockchain infrastructure.

Over two days in Abu Dhabi last week, more than 300 executives from traditional finance, the digital assets space and regulation gathered to map the deployment of tokenized finance at scale.

Tokenization Moves To Deployment

The core message of the event was that tokenization is moving from pilots to production.

It’s the clearest signal yet that tokenization is moving from concept to capital markets infrastructure. And while most of the world is focused on mega-cap use cases, AGORACOM is focused on ensuring public small and mid-cap companies will participate and thrive in this new financing model.

“The acceleration of RWA tokenization comes as no surprise to us given the fact we have spent the last two years building the partnerships, compliance guard rails and model that will make RWA tokenization possible for small and mid-cap sized public companies whose growth has been constrained by artificially depressed stock prices.” – AGORACOM Founder – George Tsiolis 

The traditional capital markets model has made it nearly impossible for small caps to grow without unnecessary dilution or inefficient financing structures. 

At AGORACOM, we’ve seen this firsthand through our work with hundreds of growth-stage CEOs, as well as our partnership with Terry Lynch and Save Canadian Mining, where we’ve helped the fight to expose the damage caused by predatory short selling.

We believe in that fight and will continue that fight – but any good plan also requires a Plan B.

Real-World Asset Tokenization Is The Solution

Through our partnerships with the likes of Dubai Blockchain Center, BlockRidge, Pegasus Fintech Group and others – AGORACOM is building an RWA framework tailored to the structure, compliance, and capital needs of emerging public companies with great assets but limited fair financing options..

If you have not already done so, watch our RWA Tokenization Showcase attended by more than 200 CEOs and industry stakeholders (click the image below)

WHY THIS UAE NEWS TURBOCHARGES AGORACOM’S RWA INITIATIVE 

  • First-Mover Advantage: AGORACOM is the only platform already building a robust AND compliant ecosystem for small-cap public companies to tokenize their assets.
  • Validation at the Highest Level: With the UAE regulators paving the way, the narrative around RWA is no longer theoretical – it’s officially endorsed by policy.
  • Liquidity at Scale: UAE capital can now flow directly into tokenized ecosystems, creating unprecedented access for small-cap issuers and investors.

The UAE’s commitment confirms what we’ve been building since George’s first visit to Dubai in February of 2023 in search of a blockchain based financing solution.

  • An Ecosystem Of Compliance, Structure and Token Experts
  • An RWA tokenization structure tailored to public companies
  • Primary and Seconday RWA Token Exchanges To Support Liquidity
  • A 2026 roadmap that aligns with a rapidly evolving RWA market
  • A trusted marketing and engagement platform already embedded in the ecosystem

BlackRock CEO Latest RWA Tokenization Comments Go Even Farther Than Ever Before

In previous updates we have quoted BlackRock CEO Larry Fink who is by far leading the transition towards tokenization of financial and real world assets.  Here are his latest comments with supporting videos:

“Tokenization is probably the most important component in the evolution of the world’s financial plumbing.”

“We’re not spending enough time talking about how quickly we’re going to tokenize every financial asset.”

If You’ve Built Real Assets It’s Time to Capitalize on Them

The future of finance is changing very rapidly to the benefit of all of us – and AGORACOM is pioneering the path for small and mid cap companies.  With the world’s leading regulators and financial titans opening the door, AGORACOM is now positioned to connect public companies to global tokenized liquidity in a smart and compliant manner. .

Fortune favours the bold.  Let’s go make history together.

Quantum BioPharma Launches USD $7 Million Reward Program for Proof of Market Manipulation

Posted by Brittany McNabb at 3:58 PM on Friday, October 31st, 2025

Quantum BioPharma (NASDAQ/CSE: QNTM) has formally launched a public whistleblower reward program, offering up to USD $7 million to any individual or entity who can provide definitive, verifiable evidence that they were asked, hired, or induced to manipulate the Company’s stock.

This initiative is directly tied to Quantum’s ongoing landmark litigation, which alleges multi-year market manipulation and seeks damages exceeding USD $700 million.

✅ Anonymous submissions are accepted
✅ Confidentiality will be protected to the fullest extent permitted by law
✅ This program does NOT replace SEC or Canadian regulatory whistleblower programs — individuals may qualify for BOTH

How to Submit Information (Direct & Confidential)

[email protected]

Ineligible to Apply

  • Current officers, directors, or employees of Quantum BioPharma
  • Government officials/regulators acting in official capacity
  • Anyone who obtained information illegally or in violation of duty
  • Anyone submitting false or fabricated information

Important Legal Clarification

Rewards are not guaranteed and will only be paid if the submitted information materially contributes to a final, non-appealable legal judgment or binding settlement in the Company’s favor.

Quantum will not use any information provided until compensation terms are agreed to in writing with the whistleblower.

For full program details and FAQ, visit: QuantumBioPharma.com
This statement is issued in the interest of market integrity and shareholder protection.

Disclaimer

This Reward Program is discretionary and subject to change or withdrawal at any time without notice. Reward eligibility does not depend on whether a whistleblower testifies, awards are based on the contribution and reliability of the information. Quantum Biopharma will not direct, script, or influence any witness testimony. Rewards are not payments for testimony. Payment of any reward is contingent upon legal review, Board approval, and the successful outcome of a final, non‑appealable judgment or binding settlement of ongoing or future litigation pursued by the Quantum BioPharma at trial to which the reported information materially contributes. Nothing in this FAQ creates a contractual right to payment. This program does not replace, restrict or limit rights under the U.S. Securities and Exchange Commission (SEC) Whistleblower Program or whistleblower programs operated by Canadian regulatory authorities, and individuals remain free to report directly to the SEC and Canadian regulatory authorities.

 

363K oz Gold at Parbec + 413 M lb NiEq at Victoria – Renforth Strengthens Dual-Asset Position in Québec

Posted by Brittany McNabb at 3:46 PM on Wednesday, October 29th, 2025

A dual-track push in gold and critical minerals underscores the junior’s scale ambitions in Canada’s Abitibi mining hub.

Background and Context

Renforth Resources Inc. (CSE: RFR; OTCQB: RFHRF; FSE: 9RR) operates in Quebec’s Abitibi, one of the world’s most established mining districts. The company controls two 100%-owned cornerstone assets: the Parbec gold deposit, situated on the Cadillac Break near Agnico Eagle’s Canadian Malartic operation, and the Victoria nickel-polymetallic system within Renforth’s ~300 km² Malartic Metals Package. Two new developments move each asset a step forward: field work has begun to expose and sample gold at surface at Parbec, and Renforth has declared an initial, pit-constrained mineral resource at Victoria.

For investors tracking both bullion and the energy transition, the pairing is notable: near-surface gold on one side; nickel, copper, zinc and precious-metal credits on the other—each with road access and hydro power in a Tier-1 jurisdiction.

Parbec: Surface Program Targets a 12.2-Meter Gold Channel

Renforth has commenced stripping and chipping overburden on the Parbec deposit inside the area outlined by its May 2025 mineral resource model. The immediate target is a surface channel that graded 1.43 grams per tonne gold over 12.2 meters on the Diorite Splay, a structure interpreted to interact with the Cadillac Break. Once exposed, the team will prospect, map and sample the newly opened bedrock to confirm continuity and test for extensions.

Why this matters: bringing modeled mineralization to surface can sharpen geologic controls, refine near-surface ounces, and inform future bulk-sampling plans. Parbec mineralization starts at surface, is largely contained within a Whittle pit, and remains open along strike and at depth; the pit shell in prior modeling does not extend below ~300 meters. The property benefits from year-round road access in close proximity to the Canadian Malartic complex.

Renforth also disclosed a non-brokered financing initiative of up to C$500,000 in units priced at C$0.02 to support ongoing work programs.

Victoria: First Nickel Polymetallic Resource Establishes Scale

On the critical-minerals side, Renforth released its maiden mineral resource estimate for the Victoria system in Malartic, Quebec: 125 million tonnes grading 0.15% nickel equivalent (NiEq), pit-constrained, representing approximately 413 million pounds of NiEq in situ. The estimate is Inferred, based on ~10,000 meters of drilling across 2.5 kilometers of strike within a ~20-kilometer mineralized trend, and remains open along strike and at depth. The deepest pierce point to date is ~320 meters; modeled pit slopes are 50 degrees with a strip ratio of less than 1:1.

Victoria’s mineralization is hosted in interlayered ultramafic units carrying nickel, cobalt, platinum and palladium, and black shale horizons bearing zinc, copper, silver and gold. Up to three stacked horizons have been intersected at surface and in drilling across a package approaching 500 meters in thickness. Two potential starter-pit subsets leverage shallow geometry and nearby infrastructure.

What Stands Out: Practical Advantages, Not Just Geology

  • Tier-1 setting: Roads, hydro power and nearby processing facilities reduce logistical risk and cost.
  • Shallow geometry: Both Parbec and Victoria emphasize near-surface mineralization that can be evaluated with rapid, lower-cost surface programs.
  • Optionality: Gold exposure at Parbec alongside nickel-polymetallic exposure at Victoria provides commodity diversification.
  • Process pathway work: Prior TOMRA ore-sorting trials and early metallurgical studies at Victoria indicate potential to pre-concentrate and float sulphide minerals, an approach aimed at reducing throughput and inputs.

Executive and Technical Commentary

Today’s Initial MRE establishes Victoria as a large-scale, near-surface polymetallic nickel system in a top-tier jurisdiction,” said President and CEO Nicole Brewster. “With our land package, hydro power, roads and nearby plants we see a path to scale. Next steps include optimization of sorting and continued step-out and infill drilling ahead of a PEA.”

Vice President of Exploration Martin Demers called the resource “an important milestone to initiate economic evaluation,” adding that geophysical anomalies point to a broader footprint and that ongoing integration of data will guide targeting within what may be a larger magmatic system.

Potential Impact and Significance

At Parbec, confirming and extending surface gold in the Diorite Splay could strengthen near-surface resource confidence and inform development sequencing inside the open-pit shell. At Victoria, the first resource converts a district-scale target into a quantified asset with room to grow. Together, the updates frame a practical work program: surface stripping, mapping and sampling at Parbec; step-outs, infill drilling and process optimization at Victoria.

Challenges and Considerations

The Victoria estimate is categorized as Inferred, reflecting early-stage confidence that will require additional drilling to upgrade to Indicated and Measured levels. Economic viability has not been demonstrated, and future studies will need to address metallurgy, recoveries, capital needs, environmental permitting and market conditions. At Parbec, translating surface channels into mineable inventory depends on consistent continuity, validated grades and subsequent technical work.

Conclusion

Renforth’s latest steps advance two parallel narratives in Quebec’s Abitibi: a surface-driven gold program at Parbec aimed at sharpening near-term understanding, and a first-pass resource at Victoria that establishes scale in nickel and associated metals. With shallow geometry, road access and power, the company is aligning field work with practical development pathways in a jurisdiction built for mining.

YOUR NEXT STEPS

Visit $RFR HUB On AGORACOM:https://agoracom.com/ir/RenforthResources

Visit $RFR 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/RenforthResources/profile

Visit $RFR Official Verified Discussion Forum On AGORACOM:https://agoracom.com/ir/RenforthResources/forums/discussion

 

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

 

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

 

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visithttps://agoracom.com/terms-and-conditions

 

The Critical Role of the Myelin Sheath – And How Quantum BioPharma Is Advancing the Next Frontier in MS Neuroprotection

Posted by Brittany McNabb at 3:39 PM on Wednesday, October 29th, 2025

Quantum BioPharma (NASDAQ/CSE: QNTM) is advancing a novel therapeutic approach to Multiple Sclerosis (MS) — one centered not on suppressing the immune system, but on targeting the underlying biology of demyelination, the core driver of neurodegeneration in MS. To understand why this approach matters, it’s critical to understand the role of the myelin sheath.

What Is the Myelin Sheath and Why Does It Matter?

The myelin sheath is a fatty, insulating layer that wraps around nerve cell axons — acting like the high-speed wiring system of the nervous system. It is produced by specialized glial cells: oligodendrocytes in the central nervous system (CNS) and Schwann cells in the peripheral nervous system.

Myelin’s value comes from four critical functions:

  • Insulation: Prevents electrical “leaks” in signal transmission
  • Speed: Enables saltatory conduction — signals “jump” node to node (up to 100× faster)
  • Efficiency: Reduces the energy neurons need to fire signals
  • System control: Supports cognition, movement, perception, and coordination

Without myelin, the electrical messages between brain and body slow, weaken, or misfire — leading to the symptoms widely associated with neurological disorders like MS.

What Happens in Multiple Sclerosis

In MS, the myelin sheath is progressively damaged — historically thought to be caused only by immune system attack. However, leading researchers now point to a second process at play: a degenerative component that occurs independently of immune activity.

Both pathways lead to demyelination — the loss or disruption of the myelin sheath — resulting in impaired communication between neurons.

This degradation is what produces the hallmark symptoms of MS:

  • Loss of motor coordination
  • Impaired sensory perception
  • Declining cognitive function
  • Fatigue and loss of balance

Quantum BioPharma’s Approach: Precision Neuroprotection

Unlike conventional immunosuppressive MS treatments, Lucid-MS – Quantum’s patented lead drug candidate — is not immunomodulatory.

Instead, it is designed to address demyelination at the biological level, advancing a neuroprotective strategy that could complement, rather than compete with, existing immune-focused treatments.

Lucid-MS has completed successful Phase 1 human safety trials, with no serious adverse events reported. Multiple animal studies have demonstrated significant activity relevant to demyelination biology, providing additional confidence as Quantum advances toward a Phase 2 clinical trial in people with MS.

A Thoughtful, Science-Driven Evolution in MS Treatment Strategy

The global MS treatment market is heavily concentrated on slowing immune system attack. Quantum BioPharma is moving deeper — focusing on the root mechanisms of nerve damage itself.

Its approach signals an evolution in neuroscience:

  • From suppression → to protection 
  • From reaction → to resilience 
  • From slowing disease → to targeting its biological engine 

Looking Ahead

Quantum BioPharma is positioning Lucid-MS within the growing global focus on regenerative and neuroprotective medicine. As regulatory preparation accelerates, the company continues to emphasize precision science, data integrity, and clinical depth — not speculation.

For official clinical progress updates, visit: www.QuantumBioPharma.com

Visit $QNTM HUB On AGORACOM :https://agoracom.com/ir/Quantumbiopharma

Visit $QNTM 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/Quantumbiopharma/profile

Visit $QNTM Official Verified Discussion Forum On AGORACOM:

https://agoracom.com/ir/Quantumbiopharma/forums/discussion

 

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post. You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews/video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

 

Kidoz Redefines Privacy-First AdTech as Global Industry Forecast to Approach $2.5 Trillion

Posted by Brittany McNabb at 4:27 PM on Tuesday, October 28th, 2025

In a digital economy where the global AdTech market is projected to surpass USD 2.5 trillion by 2032, one company is quietly redefining what it means to advertise safely and effectively—Kidoz Inc. (TSXV: KDOZ | OTCQB: KDOZF).

A Scalable AdTech Platform for the Modern Era

Kidoz operates a global, privacy-first advertising network built for the new digital reality: one where regulations, compliance, and user protection are non-negotiable. Its proprietary Kidoz Safe Ad Network and Prado SDK enable contextual, data-free campaigns that reach audiences worldwide—spanning children, teens, and families—without sacrificing performance or compliance.

The company’s technology powers high-engagement mobile campaigns across more than 60 countries, supporting a billion-plus active gamers and app users. This scale has translated into measurable results, with Kidoz reporting record first-half 2025 revenue of USD $5.17 million, a 21% year-over-year increase, and over CAD $57 million in cumulative revenue over the past three years.

Riding the AdTech Expansion Wave

Global AdTech is growing fast—driven by AI, programmatic automation, and the surge in mobile engagement. As advertisers seek ways to comply with GDPR, COPPA, and new privacy acts worldwide, Kidoz stands out as one of the few networks fully aligned with these requirements from inception.

With AI-driven contextual targeting and a real-time campaign engine, Kidoz offers a blueprint for how digital marketing can evolve without intrusive data collection. Its model fits perfectly within an industry that’s moving toward transparency, accountability, and measurable ROI.

Innovation and Strategic Growth

Behind Kidoz’s success is a commitment to constant reinvestment. In 2025, R&D spending rose 48% year-over-year, while marketing surged 95% as the company expanded global awareness. Its platform enhancements—including the proprietary Kite IQ AI engine—enable smarter ad matching, delivering relevant experiences to users while maintaining full compliance.

These strategic investments ensure Kidoz remains competitive against giants in the USD 81 billion mobile gaming ad sector, where immersive formats and interactivity are defining the next frontier of engagement.

The Power of Privacy-First Design

Regulatory pressure has become one of the strongest tailwinds in digital advertising. Global frameworks such as GDPR and CCPA demand that companies handle user data responsibly—or face steep penalties. Kidoz’s advantage lies in the fact that its systems were purpose-built for compliance.

Its infrastructure is Google-certified, Apple-approved, and among the first to align with the EU AI Act. This foundation not only minimizes risk for advertisers but also offers a scalable path to growth in sectors where user trust is paramount.

Positioning for the Next Chapter

After years of disciplined execution, Kidoz is evolving from category pioneer to category leader. It now serves as a full-stack AdTech company, offering supply-side, demand-side, and ad-exchange solutions through a unified platform.

As global ad spend continues to shift toward mobile and contextual formats, Kidoz’s privacy-first ecosystem positions it squarely within the fastest-growing segments of the AdTech market.

Bottom line:
Kidoz Inc. represents the next generation of advertising technology—one built not on user tracking, but on intelligence, integrity, and innovation. In a USD 2.5 trillion industry racing toward automation and accountability, Kidoz stands out as a company built for the future of digital engagement.

https://www.fortunebusinessinsights.com/adtech-market-110325

 

Visit $KDOZ HUB On AGORACOM: https://agoracom.com/ir/Kidoz

Visit $KDOZ 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/Kidoz/profile

Visit $KDOZ Official Verified Discussion Forum On AGORACOM:https://agoracom.com/ir/Kidoz/forums/discussion

Watch $KDOZ Videos On AGORACOM YouTube Channel:

https://www.youtube.com/feed/library

 

DISCLAIMER AND DISCLOSURE  

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

 

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

 

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

 

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

 

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

Draganfly Secures U.S. Army Contract and Expands Defense Presence

Posted by Brittany McNabb at 11:16 AM on Monday, October 27th, 2025

A Strengthening Role in U.S. Defense Innovation

Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A), a leading developer of unmanned aerial systems (UAS) and integrated drone solutions, is expanding its presence within the U.S. defense sector through a strategic partnership with Global Ordnance, a U.S. Defense Logistics Agency (DLA) prime contractor.

Under the agreement, Global Ordnance will serve as Draganfly’s U.S. defense partner for its line of drone platforms and related technologies. The collaboration will coordinate logistics, manufacturing, and deployment to accelerate defense adoption and strengthen North American supply-chain resilience.

U.S. Army Contract for Flex FPV Drone Systems
In September 2025, Draganfly announced an initial order from the U.S. Army for its Flex FPV (First Person View) drone systems. These drones are designed for high-performance operational use, enhancing agility, situational awareness, and field readiness.

The program includes support for embedded manufacturing at overseas U.S. Forces facilities, a model intended to shorten logistics timelines, improve sustainment, and ensure continuous operational capability. Draganfly will also provide training on flight operations, assembly, and maintenance, all within NDAA-compliant production standards.

A Strategic Partnership With Global Ordnance
Global Ordnance, headquartered in Florida with subsidiaries including Global Military Products and Mountain Horse LLC, brings extensive experience supporting U.S. and allied forces through logistics, program management, and tactical equipment supply.

The partnership combines Global Ordnance’s defense infrastructure with Draganfly’s proven UAV expertise to deliver mission-specific drone systems for intelligence, surveillance, reconnaissance, logistics, and tactical operations. Together, the companies will focus on scalability, secure manufacturing, and rapid-response capabilities.

Meeting the Growing Demand for Secure Drone Solutions
Global defense markets are rapidly transitioning toward secure, modular, and domestically produced UAS platforms. In the U.S., current policy emphasizes rapid procurement and the strengthening of compliant, homegrown supply chains.

Draganfly’s technology portfolio and strategic alliances align with this shift—positioning the company as a trusted North American supplier capable of supporting defense modernization efforts with adaptable, mission-driven platforms.

Leadership Perspective 

“By embedding manufacturing, training, and sustainment within U.S. Forces operations, we’re advancing readiness and resilience,” said Cameron Chell, Draganfly’s Chief Executive Officer. “Our goal is to ensure that personnel have mission-ready drone technology exactly where and when it’s needed.”

Advancing the Future of Defense Technology
With the U.S. Army’s adoption of the Flex FPV platform and the Global Ordnance partnership now in place, Draganfly is emerging as a credible North American leader in secure, mission-adaptive drone systems. These initiatives reflect the company’s continued commitment to supporting national security objectives through innovation, compliance, and operational excellence.

 

YOUR NEXT STEPS

Visit $DPRO HUB On AGORACOM:http:// https://agoracom.com/ir/Draganfly 

Visit $DPRO 5 Minute Research Profile On AGORACOM:http:// https://agoracom.com/ir/Draganfly/profile

Visit $DPRO Official Verified Discussion Forum On AGORACOM:http:// https://agoracom.com/ir/Draganfly/forums/discussion

Watch $DPRO Videos On AGORACOM YouTube Channel:

https://www.youtube.com/playlist?list=PLfL457LW0vdIXvNVrqwDRK0Pe8i_bAUzr

 

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

 

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visit http://  https://agoracom.com/terms-and-conditions